Scott Cohen

MD-PhD Student at the University of Florida | PhD in Epidemiology
Infectious Disease Epidemiology + AMR + Causal AI

[Scott Cohen @cohensa]

@nickmmark Certainly an amazing era to train in. Hard to appreciate in real time, but adult CF care was really never possible before modulators. Now the work is modulator limits, residual disease, aging with CF, and long-term sequelae it seems we are only beginning to understand.

[Scott Cohen @cohensa]

@DrToddLee @ABsteward Did you find utility in using that for potential outbreak detection? I had some success with similar approaches.

[Scott Cohen @cohensa]

@PulmCrit One is a tool, the other a design framework, often used together. Yes, observational and limited by unmeasured confounding, but good design reduces real bias, not just decorates it. We need these studies for questions RCTs can’t or won’t ever answer, so why not do them better?

[Scott Cohen @cohensa]

@Papa_Heme Not so fun fact - Ertapenem still selects for Pseudomonas multi-drug resistance despite in vitro inactivity.

[Scott Cohen @cohensa]

@alexolegimas The median number of **views** per paper is 0-1, let alone citations

[Scott Cohen @cohensa]

@IM_Crit_ What do you prefer to use for sepsis screening?

[Scott Cohen @cohensa]

@AnilMakam Nothing wrong with improving observational design. RCTs cannot be the only standard we rely on for causal questions.

[Scott Cohen @cohensa]

@BradSpellberg @ABsteward What would be your ideal endpoints for MSSA and/or MRSA bacteremia?

[Scott Cohen @cohensa]

@PulmCrit @AnilMakam Are you both unconvinced they properly controlled for baseline clinical improvement up until enrollment? The subgroup analysis and post-adjustment tables make it seem the weighting worked well.

[Scott Cohen @cohensa]

@David_Ouyang @boulware_dr I had posted chart of success rates/applications by degree from NIH Reporter but deleted it because it wasn’t research awards. Do you know if a change in number of MD-only applications can explain the decrease in proportion of awards?

[Open Forum Infectious Diseases @OFIDJournal]

Dynamic networks of methicillin-resistant Staphylococcus aureus in communities drive hospital transmission

✅ Just Accepted
🔗 https://t.co/nZyx7BnLkK

[Emerging Pathogens Institute @UF_EPI]

In the world of artificial intelligence, #UF grad student @cohensa dived into 10 years of unused data to help #hospitals.

Explore the #research that earned him first place in the EPI Research Day 2025 pre-doctoral research poster competition: https://t.co/PQrksFxnYQ.

[Scott Cohen @cohensa]

@jbcarmody Declines can be explained almost entirely by decrease in repeat applicants (presumably due to higher enrollment). First time applicants are up.

[Scott Cohen @cohensa]

@PMurawala Had a nearly identical issue on a grant. It is a problem with shared first-author papers when your name just happens to be second. Fortunately, it was entirely resolved on resubmission. There really needs to be a better system to avoid inadvertent penalty on shared authorship.

[Scott Cohen @cohensa]

@statsepi What about when trials are not possible? Wouldn’t that be “novel” treatment effects?

[Scott Cohen @cohensa]

@ZKForTre You all got nervous LV was going to trade up.

[Scott Cohen @cohensa]

Honored to be recognized at UF PHHP Days this year! Thankful for all the mentorship and support at @UFPHHP, @UF_EPI, and @UFMDPhD.

[UF College of Public Health & Health Professions @UFPHHP]

Let's give a 👏 round of applause 👏 to our PHHP Days student and faculty awardees!

To see a full list of winners, read our wrap-up story: https://t.co/QYoEWgSAXh

[Eric Topol @EricTopol]

More than 1 million people are dying each year from antibiotic resistance, considered a global health emergency. The pharma industry is doing little to respond. Thankfully academic labs, using A.I. and structure-based discovery, are kicking in. My summary Table of recent progress

[Scott Cohen @cohensa]

@IcyTonyan @SethWalder Probably around 50-60% depending on the play design

[Scott Cohen @cohensa]

@SethWalder What is the breakeven conversion percentage?